Latest Articles

Publication Date
Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026 - The Manila Times

Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026 The Manila Times

Published: June 22, 2026, 11:48 a.m.
precision medicine in endometriosis: a clinical review - OC Academy

precision medicine in endometriosis: a clinical review OC Academy

Published: June 19, 2026, 5:43 a.m.
The Role of Molecular Characterization in Precision Medicine in Endometriosis.

Endometriosis is a chronic condition in which tissue similar to the lining of the uterus grows in other parts of the body. It affects roughly 1 in 10 women of …

Published: June 18, 2026, midnight
Cyclana Bio Is Exploring the Extracellular Matrix to Treat Endometriosis - Inside Precision Medicine

Cyclana Bio Is Exploring the Extracellular Matrix to Treat Endometriosis Inside Precision Medicine

Published: June 11, 2026, 6:50 p.m.
Endometriosis-associated Pain: Mechanism, Neuroimmune Signature, and Translational Precision Strategies.

Endometriosis affects approximately 10% of reproductive-aged women worldwide and is a leading cause of chronic pelvic pain. Despite its high prevalence and substantial socioeconomic burden, the mechanisms underlying endometriosis-associated pain …

Published: June 10, 2026, midnight
Rethinking And Refining Endometrial Cancer Care In The Modern Age Of Precision Medicine Guess The Party (kYzjsSP7yP) - Mshale

Rethinking And Refining Endometrial Cancer Care In The Modern Age Of Precision Medicine Guess The Party (kYzjsSP7yP) Mshale

Published: May 27, 2026, 5:36 p.m.
Glycolytic reprogramming in endometriosis: molecular mechanisms, immune modulation, and non-hormonal therapeutic opportunities.

Endometriosis is a chronic gynecological disorder characterized by ectopic tissue growth and significant morbidity, yet current hormonal and surgical treatments often fail to prevent recurrence or entail severe side effects. …

Published: May 25, 2026, midnight
Antibody-Drug Conjugate Shows Activity in Hard-to-Treat Uterine Cancer - Inside Precision Medicine

Antibody-Drug Conjugate Shows Activity in Hard-to-Treat Uterine Cancer Inside Precision Medicine

Published: May 15, 2026, 7:12 p.m.
Endometriosis May Increase Risk of Birth Defects - Inside Precision Medicine

Endometriosis May Increase Risk of Birth Defects Inside Precision Medicine

Published: May 11, 2026, 4:01 a.m.
Bowel and Ovarian Cancer Cases Rise Among U.K. Young Adults - Inside Precision Medicine

Bowel and Ovarian Cancer Cases Rise Among U.K. Young Adults Inside Precision Medicine

Published: April 29, 2026, 5:51 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!